Mode
Text Size
Log in / Sign up

vNOTES myomectomy shows earlier first flatus but lacks clear differences in operative time or blood lossvNOTES Surgery Shows Potential for Faster Recovery After Myomectomy

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that vNOTES myomectomy shows earlier first flatus but requires more robust studies to confirm safety and efficacy.

This meta-analysis evaluates the outcomes of vaginal natural orifice transluminal endoscopic surgery (vNOTES) compared to multi-port or laparoendoscopic single-site (LESS) myomectomy for uterine leiomyoma. The analysis included 348 vNOTES cases and 272 laparoscopic cases. The study found that vNOTES was associated with a significantly earlier time to first flatus (95% CI -9.7 to -5.1). However, no clear differences were observed for operative time (95% CI -10.8 to 6.4) or blood loss (95% CI -20.2 to 16.5).

Regarding hospital stay, vNOTES showed a shorter length of stay of -0.95 days, but this finding was noted as highly heterogeneous and imprecise (I=96%). Safety data indicated that conversion occurred only in vNOTES arms (RR 5.01), and postoperative infection favored LESS in two cohorts (RR 6.00). Rectal injury occurred in 1.15% of vNOTES cases, while vaginal or cuff infections were also noted.

The authors highlight that evidence for bowel recovery is of low certainty and the overall data is event-sparse and observational. Generalizability and long-term reproductive outcomes remain uncertain. While vNOTES appears feasible in expert centers, the authors conclude that more robust comparative studies are required to establish definitive safety and efficacy profiles.

Researchers analyzed data from 620 patients undergoing myomectomy to remove uterine fibroids. They compared a newer technique called vNOTES to traditional laparoscopic methods. The study looked at several factors, including surgery time, blood loss, and how quickly patients recovered after the procedure.

The results showed that patients who had the vNOTES procedure experienced earlier first flatus, which is a sign of bowel recovery. While the length of stay in the hospital was also shorter for vNOTES patients, the data for this specific finding was inconsistent. Other factors like operative time and blood loss did not show a clear difference between the two methods.

Some safety concerns were noted, including a small number of rectal injuries and infections in the vNOTES group. Because the evidence is based on a small number of events and is not yet definitive, these results are currently used to help experts understand potential risks. More large-scale studies are needed to confirm the long-term safety and effectiveness of this technique.

What this means for you:
vNOTES may lead to faster bowel recovery after fibroid surgery, but more research is needed to confirm safety.

Common questions

What is vNOTES and how does it compare to other surgeries?

vNOTES is a type of surgery used to treat uterine fibroids. In this study, it was compared to multi-port or single-site laparoscopic surgery. While vNOTES showed a trend toward faster bowel recovery, there was no clear difference in total surgery time or the amount of blood lost during the procedure.

Are there any risks associated with vNOTES surgery?

The study reported a small number of rectal injuries (1.15%) and some vaginal or cuff infections in the vNOTES group. Because these events were rare, experts consider them as signals to watch rather than confirmed risks. You should talk to your doctor about the specific risks of any surgical method.

Does vNOTES help patients stay in the hospital for less time?

Patients who underwent vNOTES had a shorter hospital stay on average. However, the researchers noted that this specific finding was inconsistent across different groups. Because the evidence for this is currently considered low-certainty, it is not yet a definitive way to predict recovery time.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
BACKGROUND: Vaginal natural orifice transluminal endoscopic surgery (vNOTES) avoids abdominal incisions and is increasingly used for benign gynecologic surgery, but evidence for fertility-sparing myomectomy remains limited. METHODS: We searched PubMed, MEDLINE, EMBASE and Scopus (January 1, 2000 - July 31, 2025) for comparative studies (vNOTES vs. multi-port or laparoendoscopic single-site [LESS] myomectomy) and single-arm vNOTES cohorts. Two reviewers screened/extracted data. Risk of bias was assessed using Newcastle-Ottawa (comparative) and Joanna Briggs Institute (JBI; case series). Random-effects meta-analysis (inverse-variance) was performed when mean ± standard deviation (SD) were available; heterogeneity was assessed with I. RESULTS: Seven studies were included (three comparative; four single-arm), totaling 348 vNOTES and 272 laparoscopic cases. Three cohorts contributed to the meta-analysis of vNOTES versus LESS for operative time, blood loss, length of stay, time to first flatus, and conversion; two cohorts contributed to infection pooling. There was no clear difference in operative time (mean differences [MD] -2.2 min, 95% confidence interval [CI] -10.8 to 6.4) or blood loss (MD -1.9 mL, 95% CI -20.2 to 16.5). vNOTES was associated with earlier first flatus (MD -7.4 h, 95% CI -9.7 to -5.1). Length of stay was shorter but highly heterogeneous and imprecise (MD -0.95 days, 95% CI -2.28 to 0.38; I=96%). Postoperative infection estimates favored LESS in two cohorts (RR 6.00, 95% CI 1.10 to 32.63). Conversion was uncommon but occurred only in vNOTES arms (RR 5.01, 95% CI 0.89 to 28.15). Across all vNOTES cohorts, rectal injury occurred in 4/348 (1.15%). CONCLUSIONS: In highly selected patients treated in expert centres, vNOTES myomectomy appears feasible, with low-certainty evidence suggesting earlier bowel recovery versus LESS. However, the available comparative evidence is event-sparse and observational; reported rectal injuries and vaginal/cuff infections should be interpreted as hypothesis-generating safety signals rather than definitive comparative risks. Generalizability and long-term reproductive outcomes remain uncertain, as there is need for more robust evidence from comparative studies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.